A new chapter in the bisphenol a story: Bisphenol S and bisphenol F are not safe alternatives to this compound

Fertility and Sterility

Volumn 103, Issue 1, 2015, Pages 11-21

  Eladak, Soria ^a,b,c   Grisin, Tiphany ^a,b,c   Moison, Delphine ^a,b,c   Guerquin, Marie Justine ^a,b,c   N'Tumba Byn, Thierry ^a,b,c   Pozzi Gaudin, Stéphanie ^d   Benachi, Alexandra ^d   Livera, Gabriel ^a,b,c   Rouiller Fabre, Virginie ^a,b,c   Habert, René ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^c INSERM   (France)

^d HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Bisphenol A; Bisphenol F; Bisphenol S; BPA; BPF; BPS; Endocrine disruptors; Environmental health; Fetus; Human; Insl3; Leydig cells; Organotypic culture; Species differences; Testis; Testosterone

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BISPHENOL F; BISPHENOL S; ENDOCRINE DISRUPTOR; PHENOL DERIVATIVE; TESTOSTERONE; UNCLASSIFIED DRUG; BENZHYDRYL DERIVATIVE; BIS(4-HYDROXYPHENYL)SULFONE; BISPHENOL F DIGLYCIDYL ETHER; EPOXIDE; POLLUTANT; SULFONE;

DOSE RESPONSE; EXPLANT; FETUS; FETUS DEVELOPMENT; GENE EXPRESSION; HEALTH HAZARD; HUMAN; IN VITRO STUDY; LEYDIG CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; TESTIS; TESTIS DEVELOPMENT; TESTOSTERONE RELEASE; ADVERSE EFFECTS; ANIMAL; CHEMICALLY INDUCED; COMPARATIVE STUDY; DRUG EFFECTS; DRUG SUBSTITUTION; EMBRYOLOGY; FEMALE; PATHOPHYSIOLOGY; POLLUTANT; PREGNANCY; PRENATAL EXPOSURE; PROCEDURES; RISK ASSESSMENT; SPECIES DIFFERENCE; TOXICITY;

ANIMALS; BENZHYDRYL COMPOUNDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SUBSTITUTION; ENDOCRINE DISRUPTORS; ENVIRONMENTAL POLLUTANTS; EPOXY COMPOUNDS; FEMALE; HUMANS; MALE; MICE; PHENOLS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RISK ASSESSMENT; SPECIES SPECIFICITY; SULFONES; TESTIS;

EID: 84924358971     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2014.11.005     Document Type: Review

References (96)

1. Carson R, Darling L, Darling L. Silent spring. Cambridge, Massachusetts: Riverside Press; 1962.
2. Colborn T, vom Saal FS, Soto AM. Developmental effects of endocrinedisrupting chemicals in wildlife and humans. Environ Health Perspect 1993;101:378-84.
3. Dodds EC, Lawson W. Synthetic oestrogenic agents without the phenanthrene nucleus. Nature 1936;137:996.
4. Zalko D, Jacques C, Duplan H, Bruel S, Perdu E. Viable skin efficiently absorbs and metabolizes bisphenol A. Chemosphere 2011;82:424-30.
5. Vandenberg LN, Hunt PA, Myers JP, Vom Saal FS. Human exposures to bisphenol A: mismatches between data and assumptions. Rev Environ Health 2013;28:37-58.
6. Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, Schoenfelder G. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect 2010;118:1055-70.
7. Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, Schoenfelder G. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Cien Saude Colet 2012;17:407-34.
8. Alonso-Magdalena P, Ropero AB, Soriano S, Garcia-Arevalo M, Ripoll C, Fuentes E, et al. Bisphenol-A acts as a potent estrogen via nonclassical estrogen triggered pathways. Mol Cell Endocrinol 2012;355:201-7.
9. Teeguarden JG, Calafat AM, Ye X, Doerge DR, Churchwell MI, Gunawan R, et al. Twenty-four hour human urine and serum profiles of bisphenol a during high-dietary exposure. Toxicol Sci 2011;123:48-57.
10. Fenichel P, Dechaux H, Harthe C, Gal J, Ferrari P, Pacini P, et al. Unconjugated bisphenol A cord blood levels in boys with descended or undescended testes. Hum Reprod 2012;27:983-90.
11. Ikezuki Y, Tsutsumi O, Takai Y, Kamei Y, Taketani Y. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod 2002;17:2839-41.
12. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr, Lee DH, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 2012;33:378-455.
13. Rochester JR. Bisphenol A and human health: a review of the literature. Reprod Toxicol 2013;42:132-55.
14. Rezg R, El-Fazaa S, Gharbi N, Mornagui B. Bisphenol A and human chronic diseases: current evidences, possible mechanisms, and future perspectives. Environ Int 2014;64:83-90.
15. Richter CA, Birnbaum LS, Farabollini F, Newbold RR, Rubin BS, Talsness CE, et al. In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 2007;24:199-224.
16. Vandenberg LN. Nonmonotonic dose responses in studies of endocrine disrupting chemicals: bisphenol a as a case study. Dose Response 2014;12:259-76.
17. Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P, Guillette LJ Jr, et al. Male reproductive health and environmental xenoestrogens. Environ Health Perspect 1996;104(Suppl 4):741-803.
18. Sharpe RM, Irvine DS. How strong is the evidence of a link between environmental chemicals and adverse effects on human reproductive health? BMJ 2004;328:447-51.
19. Leridon H, Slama R. The impact of a decline in fecundity and of pregnancy postponement on final number of children and demand for assisted reproduction technology. Hum Reprod 2008;23:1312-9.
20. Main KM, Skakkebaek NE, Virtanen HE, Toppari J. Genital anomalies in boys and the environment. Best Pract Res Clin Endocrinol Metab 2010;24:279-89.
21. Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for decreasing quality of semen during past 50 years. BMJ 1992;305:609-13.
22. Cocuzza M, Esteves SC. Shedding light on the controversy surrounding the temporal decline in human sperm counts: a systematic review. Sci World J 2014;2014:365691.
23. Rolland M, le Moal J, Wagner V, Royere D, de Mouzon J. Decline in semen concentration and morphology in a sample of 26,609 men close to general population between 1989 and 2005 in France. Hum Reprod 2013;28:462-70.
24. le Moal J, Rolland M, Goria S, Wagner V, de Crouy-Chanel P, Rigou A, et al. Semen quality trends in French regions are consistent with a global change in environmental exposure. Reproduction 2014;147:567-74.
25. Skakkebaek NE, Rajpert-de Meyts E, Jorgensen N, Main KM, Leffers H, Andersson AM, et al. Testicular cancer trends as "whistle blowers" of testicular developmental problems in populations. Int J Androl 2007;30:198-204.
26. Toppari J, Virtanen HE, Main KM, Skakkebaek NE. Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental connection. Birth Defects Res A Clin Mol Teratol 2010;88:910-9.
27. Sharpe RM, Skakkebaek NE. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 1993;341:1392-5.
28. Delbes G, Levacher C, Habert R. Estrogen effects on fetal and neonatal testicular development. Reproduction 2006;132:527-38.
29. Giwercman A, Giwercman YL. Environmental factors and testicular function. Best Pract Res Clin Endocrinol Metab 2011;25:391-402.
30. Virtanen HE, Adamsson A. Cryptorchidism and endocrine disrupting chemicals. Mol Cell Endocrinol 2012;355:208-20.
31. Svechnikov K, Stukenborg JB, Savchuck I, Soder O. Similar causes of various reproductive disorders in early life. Asian J Androl 2014;16:50-9.
32. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001;16:972-8.
33. Olesen IA, Sonne SB, Hoei-Hansen CE, Rajpert-De Meyts E, Skakkebaek NE. Environment, testicular dysgenesis and carcinoma in situ testis. Best Pract Res Clin Endocrinol Metab 2007;21:462-78.
34. Jost A, Vigier B, Prepin J, Perchellet JP. Studies on sex differentiation in mammals. Recent Prog Horm Res 1973;29:1-41.
35. Scott HM, Mason JI, Sharpe RM. Steroidogenesis in the fetal testis and its susceptibility to disruption by exogenous compounds. Endocr Rev 2009;30:883-925.
36. Habert R, Muczynski V, Lehraiki A, Lambrot R, Lecureuil C, Levacher C, et al. Adverse effects of endocrine disruptors on the foetal testis development: focus on the phthalates. Folia Histochem Cytobiol 2009;47:S67-74.
37. Gaspari L, Paris F, Philibert P, Audran F, Orsini M, Servant N, et al. "Idiopathic"partial androgen insensitivity syndrome in 28 newborn and infant males: impact of prenatal exposure to environmental endocrine disruptor chemicals? Eur J Endocrinol 2011;165:579-87.
38. Welsh M, Saunders PT, Fisken M, Scott HM, Hutchison GR, Smith LB, et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest 2008;118:1479-90.
39. Macleod DJ, Sharpe RM, Welsh M, Fisken M, Scott HM, Hutchison GR, et al. Androgen action in the masculinization programming window and development of male reproductive organs. Int J Androl 2010;33:279-87.
40. Higuchi TT, Palmer JS, Gray LE Jr, Veeramachaneni DN. Effects of dibutyl phthalate in male rabbits following in utero, adolescent, or postpubertal exposure. Toxicol Sci 2003;72:301-13.
41. Mahood IK, Scott HM, Brown R, Hallmark N, Walker M, Sharpe RM. In utero exposure to di(n-butyl) phthalate and testicular dysgenesis: comparison of fetal and adult end points and their dose sensitivity. Environ Health Perspect 2007;115(Suppl 1):55-61.
42. Thuillier R, Manku G, Wang Y, Culty M. Changes in MAPK pathway in neonatal and adult testis following fetal estrogen exposure and effects on rat testicular cells. Microsc Res Tech 2009;72:773-86.
43. Peretz J, Vrooman L, Ricke WA, Hunt PA, Ehrlich S, Hauser R, et al. Bisphenol a and reproductive health: update of experimental and human evidence, 2007-2013. Environ Health Perspect 2014;122:775-86.
44. Salian S, Doshi T, Vanage G. Perinatal exposure of rats to bisphenol A affects the fertility of male offspring. Life Sci 2009;85:742-52.
45. Murray TJ, Maffini MV, Ucci AA, Sonnenschein C, Soto AM. Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure. Reprod Toxicol 2007;23:383-90.
46. Howdeshell KL, Furr J, Lambright CR, Wilson VS, Ryan BC, Gray LE Jr. Gestational and lactational exposure to ethinyl estradiol, but not bisphenol A, decreases androgen-dependent reproductive organ weights and epididymal sperm abundance in the male long evans hooded rat. Toxicol Sci 2008;102:371-82.
47. Kobayashi K, Miyagawa M, Wang RS, Sekiguchi S, Suda M, Honma T. Effects of in utero and lactational exposure to bisphenol A on somatic growth and anogenital distance in F1 rat offspring. Ind Health 2002;40:375-81.
48. Tyl RW, Myers CB, Marr MC, Thomas BF, Keimowitz AR, Brine DR, et al. Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats. Toxicol Sci 2002;68:121-46.
49. LaRocca J, Boyajian A, Brown C, Smith SD, Hixon M. Effects of in utero exposure to bisphenol A or diethylstilbestrol on the adult male reproductive system. Birth Defects Res B Dev Reprod Toxicol 2011;92:526-33.
50. Tanaka M, Nakaya S, Katayama M, Leffers H, Nozawa S, Nakazawa R, et al. Effect of prenatal exposure to bisphenol A on the serum testosterone concentration of rats at birth. Hum Exp Toxicol 2006;25:369-73.
51. Miao M, Yuan W, He Y, Zhou Z, Wang J, Gao E, et al. In utero exposure to bisphenol-A and anogenital distance of male offspring. Birth Defects Res A Clin Mol Teratol 2011;91:867-72.
52. Choi H, Kim J, Im Y, Lee S, Kim Y. The association between some endocrine disruptors and hypospadias in biological samples. J Environ Sci Health A Tox Hazard Subst Environ Eng 2012;47:2173-9.
53. Fenichel P, Chevalier N, Brucker-Davis F. Bisphenol A: an endocrine and metabolic disruptor. Ann Endocrinol (Paris) 2013;74:211-20.
54. Ivell R, Anand-Ivell R. Biology of insulin-like factor 3 in human reproduction. Hum Reprod Update 2009;15:463-76.
55. Habert R, Devif I, Gangnerau MN, Lecerf L. Ontogenesis of the in vitro response of rat testis to gonadotropin-releasing hormone. Mol Cell Endocrinol 1991;82:199-206.
56. Habert R, Muczynski V, Grisin T, Moison D, Messiaen S, Frydman R, et al. Concerns about the widespread use of rodent models for human risk assessments of endocrine disruptors. Reproduction 2014;147:R119-29.
57. Habert R, Livera G, Rouiller-Fabre V. Man is not a big rat: concerns with traditional human risk assessment of phthalates based on their antiandrogenic effects observed in the rat foetus. Basic Clin Androl 2014;24:14.
58. N'Tumba-Byn T, Moison D, Lacroix M, Lecureuil C, Lesage L, Prud'homme SM, et al. Differential effects of bisphenol A and diethylstilbestrol on human, rat and mouse fetal Leydig cell function. PLoS One 2012;7:e51579.
59. Olaso R, Pairault C, Boulogne B, Durand P, Habert R. Transforming growth factor beta1 and beta2 reduce the number of gonocytes by increasing apoptosis. Endocrinology 1998;139:733-40.
60. Livera G, Rouiller-Fabre V, Durand P, Habert R. Multiple effects of retinoids on the development of Sertoli, germ, and Leydig cells of fetal and neonatal rat testis in culture. Biol Reprod 2000;62:1303-14.
61. Delbes G, Levacher C, Duquenne C, Racine C, Pakarinen P, Habert R. Endogenous estrogens inhibit mouse fetal Leydig cell development via estrogen receptor alpha. Endocrinology 2005;146:2454-61.
62. Livera G, Delbes G, Pairault C, Rouiller-Fabre V, Habert R. Organotypic culture, a powerful model for studying rat and mouse fetal testis development. Cell Tissue Res 2006;324:507-21.
63. Lambrot R, Coffigny H, Pairault C, Donnadieu AC, Frydman R, Habert R, et al. Use of organ culture to study the human fetal testis development: effect of retinoic acid. J Clin Endocrinol Metab 2006;91:2696-703.
64. Lambrot R, Livera G, Coffigny H, Pairault C, Frydman R, Habert R, et al. A new method for toxicity assays on human and mouse fetal testis. Biochimie 2006;88:1831-5.
65. Delbes G, Duquenne C, Szenker J, Taccoen J, Habert R, Levacher C. Developmental changes in testicular sensitivity to estrogens throughout fetal and neonatal life. Toxicol Sci 2007;99:234-43.
66. Habert R, Lejeune H, Saez JM. Origin, differentiation and regulation of fetal and adult and adult Leydig Cells. Mol Cell Endocrinol 2001;179:47-74.
67. Svechnikov K, Landreh L, Weisser J, Izzo G, Coloń E, Svechnikova I, et al. Origin, development and regulation of human Leydig cells. Horm Res Paediatr 2010;73:93-101.
68. Habert R, Picon R. Testosterone, dihydrotestosterone and estradiol-17 beta levels in maternal and fetal plasma and in fetal testes in the rat. J Steroid Biochem 1984;21:193-8.
69. Picon R, Habert R. A sensitive bioassay for luteinizing hormone like activity applied to systemic plasma of foe tal rats. Acta Endocrinol (Copenh) 1981;97:176-80.
70. Habert R, Picon R. Control of testicular steroidogenesis in foetal rat: effect of decapitation on testosterone and plasma luteinizing hormone-like activity. Acta Endocrinol (Copenh) 1982;99:466-73.
71. Carr FE, Chin WW. Absence of detectable chorionic gonadotropin subunit messenger ribonucleic acids in the rat placenta throughout gestation. Endocrinology 1985;116:1151-7.
72. Strauss BL, Pittman R, Pixley MR, Nilson JH, Boime I. Expression of b subunit of chorionic gonadotropin in transgenic mice. J Biol Chem 1994;269:4968-73.
73. Fowler PA, Childs AJ, Courant F, MacKenzie A, Rhind SM, Antignac JP, et al. In utero exposure to cigarette smoke dysregulates human fetal ovarian developmental signalling. Hum Reprod 2014;29:1471-89.
74. Habert R. Effect of decapitation and chronic in-vivo treatment with a gonadotrophin-releasing hormone agonist on testicular steroidogenesis in the rat fetus. J Endocrinol 1992;133:245-51.
75. Migrenne S, Pairault C, Racine C, Livera G, Geloso A, Habert R. Luteinizing hormone-dependent activity and luteinizing hormone-independent differentiation of rat fetal Leydig cells. Mol Cell Endocrinol 2001;172:193-202.
76. Lehraiki A, Racine C, Krust A, Habert R, Levacher C. Phthalates impair germ cell number in the mouse fetal testis by an androgen- and estrogenindependent mechanism. Toxicol Sci 2009;111:372-82.
77. Culty M, Thuillier R, Li W, Wang Y, Martinez-Arguelles DB, Benjamin CG, et al. In utero exposure to di-(2-ethylhexyl) phthalate exerts both shortterm and long-lasting suppressive effects on testosterone production in the rat. Biol Reprod 2008;78:1018-28.
78. Habert R, Brignaschi P. Developmental changes in in vitro testosterone production by dispersed Leydig cells during fetal life in rats. Arch Androl 1991;27:65-71.
79. Ben Maamar M, Lesné L, Desdoigts-Lethimonier C, Coiffec I, Lavoué V, Dejucq-Rainsford N, et al. Effect of bisphenol A on the rat and human fetal testis. In: 18th European Testis Workshop. Elsinore, Denmark, 2014.
80. Akingbemi BT, Sottas CM, Koulova AI, Klinefelter GR, Hardy MP. Inhibition of testicular steroidogenesis by the xenoestrogen bisphenol A is associated with reduced pituitary luteinizing hormone secretion and decreased steroidogenic enzyme gene expression in rat Leydig cells. Endocrinology 2004;145:592-603.
81. Ji K, Hong S, Kho Y, Choi K. Effects of bisphenol s exposure on endocrine functions and reproduction of zebrafish. Environ Sci Technol 2013;47:8793-800.
82. Molina-Molina JM, Amaya E, Grimaldi M, Saenz JM, Real M, Fernandez MF, et al. In vitro study on the agonistic and antagonistic activities of bisphenol-S and other bisphenol-A congeners and derivatives via nuclear receptors. Toxicol Appl Pharmacol 2013;272:127-36.
83. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252-63.
84. Kubo T, Maezawa N, Osada M, Katsumura S, Funae Y, Imaoka S. Bisphenol A, an environmental endocrine-disrupting chemical, inhibits hypoxic response via degradation of hypoxia-inducible factor 1alpha (HIF-1alpha): structural requirement of bisphenol A for degradation of HIF-1alpha. Biochem Biophys Res Commun 2004;318:1006-11.
85. Peyre L, Rouimi P, de Sousa G, Helies-Toussaint C, Carre B, Barcellini S, et al. Comparative study of bisphenol A and its analogue bisphenol S on human hepatic cells: a focus on their potential involvement in nonalcoholic fatty liver disease. Food Chem Toxicol 2014;70:9-18.
86. Vinas R, Watson CS. Bisphenol S disrupts estradiol-induced nongenomic signaling in a rat pituitary cell line: effects on cell functions. Environ Health Perspect 2013;121:352-8.
87. Audebert M, Dolo L, Perdu E, Cravedi JP, Zalko D. Use of the gammaH2AX assay for assessing the genotoxicity of bisphenol A and bisphenol F in human cell lines. Arch Toxicol 2011;85:1463-73.
88. Helies-Toussaint C, Peyre L, Costanzo C, Chagnon MC, Rahmani R. Is bisphenol S a safe substitute for bisphenol A in terms of metabolic function? An in vitro study. Toxicol Appl Pharmacol 2014;280:224-35.
89. Kidani T, Kamei S, Miyawaki J, Aizawa J, Sakayama K, Masuno H. Bisphenol A downregulates Akt signaling and inhibits adiponectin production and secretion in 3T3-L1 adipocytes. J Atheroscler Thromb 2010;17:834-43.
90. Rosenmai AK, Dybdahl M, Pedersen M, Alice van Vugt-Lussenburg BM, Wedebye EB, Taxvig C, et al. Are structural analogues to bisphenol a safe alternatives? Toxicol Sci 2014;139:35-47.
91. Liao C, Liu F, Kannan K. Bisphenol S, a new bisphenol analogue, in paper products and currency bills and its association with bisphenol a residues. Environ Sci Technol 2012;46:6515-22.
92. Liao C, Kannan K. Concentrations and profiles of bisphenol A and other bisphenol analogues in foodstuffs from the United States and their implications for human exposure. J Agric Food Chem 2013;61:4655-62.
93. Liao C, Liu F, Alomirah H, Loi VD, Mohd MA, Moon HB, et al. Bisphenol S in urine from the United States and seven Asian countries: occurrence and human exposures. Environ Sci Technol 2012;46:6860-6.
94. Nanjappa MK, Simon L, Akingbemi BT. The industrial chemical bisphenol A (BPA) interferes with proliferative activity and development of steroidogenic capacity in rat Leydig cells. Biol Reprod 2012;86:135, 1-12.
95. Takamiya M, Lambard S, Huhtaniemi IT. Effect of bisphenol A on human chorionic gonadotrophin-stimulated gene expression of cultured mouse Leydig tumour cells. Reprod Toxicol 2007;24:265-75.
96. Zhang X, Chang H, Wiseman S, He Y, Higley E, Jones P, et al. Bisphenol A disrupts steroidogenesis in human H295R cells. Toxicol Sci 2011;121:320-7.